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between  genotypes  when  mice 
were fed CD (WT, 0.48 ± 0.09 mM; 
A1R–/–, 0.60 ± 0.09 mM; n = 5 per 
group, P  > 0.05),  and  there was 
no  evidence  for  inadequate  or 
decreased ketones in A1R–/– mice 
fed KD  for  3 weeks. βHB  levels 
were  elevated  similarly  and  sig-
nificantly  in  both  genotypes  in 
KD-  versus  CD-fed  mice  (WT, 
P < 0.001; A1R–/–, P < 0.002); over-
all,  KD-fed A1R–/– mice  demon-
























Seizure frequency and duration
	 CD	 KD	 KD	plus	 KD	plus	
	 	 	 glucose	 DPCPX
Frequency	(seizures/h)
WT 0 0 0 0
Adk-Tg 4.8 ± 0.4 0.6 ± 0.2A 4.1 ± 0.2B,C 4.9 ± 0.5C
A1R+/– 3.8 ± 0.7 1.8 ± 0.4A 3.4 ± 0.3C 3.9 ± 0.7C
A1R–/– 5.3 ± 0.6 5.1 ± 0.6 5.2 ± 0.5 4.9 ± 0.5
Duration	(s)
WT 0 0 0 0
Adk-Tg 26.8 ± 3.3 14.4 ± 4.0A 18.6 ± 2.0B,D 37.6 ± 4.3A,C
A1R+/– 16.4 ± 1.6 15.9 ± 4.2 16.2 ± 2.1 16.4 ± 2.2
A1R–/– 27.9 ± 2.4 29.3 ± 2.9 31.2 ± 4.9 29.9 ± 3.1
Mice were maintained on CD or KD for 3 weeks. KD reduced spon-
taneous seizures in Adk-Tg and A1R+/– mice and was ineffective in 
A1R–/– mice; glucose (2 g/kg i.p.) or DPCPX (1 mg/kg i.p.) reversed its 
anti-ictogenic effects. Values are mean ± SD. n = 10 (CD, KD); 5 (KD 
plus glucose, KD plus DPCPX). AP < 0.001, BP < 0.05 vs. CD.  
CP < 0.001, DP < 0.05 vs. KD alone.
Figure 1
Seizure suppression by KD depends on A1R activation. Representative EEG recordings from the CA3 of 
WT and transgenic mice reflect seizure distribution over a 1-hour time span (top traces) and individual 
seizures at higher resolution (1 minute; bottom traces). Asterisks in top traces denote the individual 
seizures chosen. Beginning and end of seizures are marked by vertical arrows. Traces from CD-fed ani-
mals showed baseline seizure activity in all mutants and lack of seizures in WT. KD almost completely 
abolished seizures in Adk-Tg mice; rare seizures were of reduced duration, as shown. KD reduced 
seizure activity in A1R+/– mice, had no effect in A1R–/– mice. Treatment with glucose or DPCPX reversed 
KD effects. See Table 1 for quantitation.
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KD leads to downregulation of ADK. (A) Representative Western blot 
from brain extracts of WT mice fed CD or KD for 3 and 4 weeks. Note 
the 2 different splice variants of ADK in the ADK-reactive bands. Anti-
tubulin immunoreactivity was used to normalize for equal loading. Lanes 
were run on the same gel but were noncontiguous (white line). (B) Brain 
ADK from mice fed CD or KD for 3–4 weeks, expressed relative to CD 
(n = 4 per group). Data are mean ± SEM. **P < 0.01 vs. CD.
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ADK immunoreactivity in hippocampus of control and TLE patients with medial temporal HS. (A–D) Sections were counterstained with hema-
toxylin. Shown are representative CA1 (A and B) and hilus (C and D) from the same sample. (A and C) Control hippocampus showed weak ADK 
immunoreactivity. Histologically normal surgical hippocampus displayed an immunoreactivity pattern similar to that in control autopsy hippocam-
pus (not shown). (B and D) The HS specimen demonstrated increased ADK expression in both residual pyramidal and hilar neurons (arrows 
and B, top inset) and in reactive astrocytes (arrowheads and B, bottom inset). Insets in D show expression of ADK (red) in a reactive astrocyte 
(GFAP, green). Scale bars: 160 μm (A and B); 80 μm (C and D); 40 μm (A, inset, and B, top inset); 15 μm (B, bottom inset, and D, insets). (E and 
F) Western blot analysis of ADK of total homogenates from control autopsy hippocampus and HS specimens. (E) Representative immunoblots. 
(F) Densitometric data, expressed relative to optical density of β-actin (n = 5 per group). Data are mean ± SEM. *P < 0.05 vs. control. 
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bolic  autocrine  regulation of neurons  involves 














overexpression  of  adenosine  kinase  aggravates 
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